Table 10.
Psychopathy-Related Effects: Neutral Explicit vs. Neutral Implicit
| Label | X | Y | Z | t-value | p-value (FDR) | r (effect size) | |
|---|---|---|---|---|---|---|---|
| Tot Neg. | L. Middle Occipital* | −33 | −87 | 12 | 3.91 | .029 | .34 |
| F1 Neg. | L. Inferior Occipital * | −33 | −87 | −9 | 3.58 | .025 | .31 |
| L. Middle Occipital* | −36 | −84 | 12 | 4.23 | .012 | .36 | |
| L. Cuneus# | −15 | −84 | 33 | 3.58 | .037 | .31 | |
| R. Cuneus# | 9 | −93 | 18 | 3.46 | .040 | .30 | |
| F2 Pos. | Bilateral Amygdala*# | −18 | −6 | −12 | 3.88 | .010 | .34 |
| L. Amygdala*# | −21 | −6 | −12 | 3.56 | .007 | .32 |
Coordinates are given in MNI space; Tot: PCL-R total score; F1: PCL-R Factor 1; F2: PCL-R Factor 2; Pos: positive linear relationship;
indicates effects significant with primary covariates (age, IQ, and substance use severity);
indicates effects significant with standard covariates and both PCL-R factors as covariates.